Trials / Completed
CompletedNCT00290914
Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pharmacology Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vilazodone |
Timeline
- First posted
- 2006-02-13
- Last updated
- 2012-05-09
Source: ClinicalTrials.gov record NCT00290914. Inclusion in this directory is not an endorsement.